当前位置: 首页 > 期刊 > 《现代医药卫生》 > 2008年第12期
编号:11622550
靶向DNA特异性B细胞在系统性红斑狼疮中的治疗研究进展(2)
http://www.100md.com 2008年6月15日 《现代医药卫生》 2008年第12期
     [6] Mohan C,Shi Y,Laman JD,et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis[J]. J Im-munol,1995,154(3):1470.

    [7] Sfikakis PP,Via CS. Expression of CD28,CTLA4,CD80, and CD86 molecules in patients with autoimmune rheumatic diseases:implica-tions for immunotherapy[J].Clin Immunol Immunopathol,1997,83(3) :195.

    [8] Fan GC,Singh RR.Vaccination with minigenes encoding V(H)-de-rived major histocompatibility complex class I-binding epitopes acti-vates cytotoxic T cellsthatablateautoantibody-producing B cells and inhibit lupus[J].J Exp Med,2002,196(6):731.

    [9] 翟志芳,刁庆春,郝 飞,等. 重组嵌合毒素Dsg3EC(1-2)PE40对寻常型天疱疮患者T、B淋巴细胞的影响[J].中华皮肤科杂志,2005,38(9):536.

    [10] 黄文广,罗 威,黄汉菊,等. 靶向DF3的白喉毒素A链基因对乳腺癌细胞的杀伤作用[J].中华实验外科杂志,2007,24(1):15.

    [11] Hong NM,MasukoHK,Sasakawa H,et al. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus2prone mice (gld) by Fas-ligand gene transfer[J].J Autoimmun,1998,11(4):301.

    [12] Chuzhin Y,Reddy B,Budhai L,et al. Prolonged survival in murine SLE by adenoviral mediated CTLA4Ig gene transfer[J].Arthritis Rheum,1998,41(l):140.

    收稿日期:2008-03-04, http://www.100md.com(杨 曌 王惠明)
上一页1 2